CTOs on the Move


 
In 2015, five seminal randomized controlled trials were published in the neurovascular space demonstrating endovascular thrombectomy to be the new gold standard for treating large vessel occlusion strokes. During that same year, advancements in artificial intelligence and deep learning made it possible to analyze medical imaging rapidly and accurately. However, despite having proven effective interventions for stroke, most stroke patients were getting treatment late or not at all. At Stanford University, Dr. Chris Mansi (neurosurgeon) and Dr. David Golan (machine learning researcher) identified this problem and together they sought to change it.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.viz.ai

  • San Francisco, CA USA
  • Phone: 866.849.4980

Executives

Name Title Contact Details
Gad Sakin
CTO Profile

Funding

Viz raised $21M on 07/18/2018
Viz raised $50M on 10/23/2019
Viz raised $71M on 03/17/2021

Similar Companies

Neurolens

Modern lifestyles and persistent near vision utilization cause a majority of patients to experience the reduced visual acuity and painful symptoms of eye misalignment – headaches, eye strain, neck and shoulder pain, motion sickness and dry eye sensation. Neurolens addresses common binocular vision issues using a three-step process. Step one is efficiently identifying patient symptomology using a basic online symptom screener that every patient can complete in minutes. This information goes directly to the Neurolens Measurement Device, Gen 2—or NMD2—ready for step two, which is accurately and objectively measuring the patient`s level of misalignment. The NMD2 is an objective, accurate and repeatable way to measure eye misalignment as small as 0.01 Prism Diopters. Most importantly, step three is correcting eye misalignment with a proven lens solution. Neurolenses address binocular vision issues by providing a contoured prism lens design that gradually delivers more prism in the lens corridor from distance to near. Neurolenses are proven to have a profound impact on a patient`s visual clarity and comfort. In fact, 93% of patients responded positively to wearing Neurolenses. Over 81% of patients suffering from chronic daily headaches reported their symptoms were substantially reduced or basically gone after wearing Neurolenses for 90 days. Neurolens—recognized in 2022 as one of the 30 fastest growing private companies in the healthcare industry by Inc. Magazine—is confident that appropriately addressing growing binocular vision issues will become a standard of care in this industry, unlocking dramatic patient outcomes and practice growth.

Hermell Products

Hermell Products is a Bloomfield, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hot Dog Patient Warming

Hot Dog Patient Warming is a Eden Prairie, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Advanced Medical Equipment

Advanced Medical Equipment is a Dayton, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

G.I. Windows

GIW is a clinical stage company creating a new category in healthcare designed to create less invasive surgery & reduce healthcare costs